COR
Cencora·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 0
Consensus Rating "Buy"
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About COR
Cencora, Inc.
One of the world's largest pharmaceutical procurement and distribution services companies
Healthcare Providers and Services
--
12/16/1993
New York Stock Exchange
47,000
09-30
Common stock
1 West First Avenue, Conshohocken, PA 19428-1800
--
Cencora, Inc., one of the world's largest pharmaceutical procurement and distribution services companies, helps healthcare providers and pharmaceutical and biotechnology manufacturers improve patient access to products that enhance patient care. The company provides innovative programs and services designed to improve the efficacy and efficiency of the pharmaceutical supply chain in human and animal health. More specifically, the company offers a comprehensive range of branded, specialty brand and generic pharmaceuticals, over-the-counter medical products, home medical supplies and equipment, and related services to a variety of healthcare providers located in the United States and select global markets, including acute hospital and health systems, independent and chain retail pharmacies, mail-order pharmacies, clinics, long-term care and alternative location pharmacies, physician practices, medical and dialysis clinics, veterinary and other clients. In addition, the company provides various related services to healthcare providers and pharmaceutical manufacturers, including data analysis, outcome research, reimbursement and drug consulting services, niche quality logistics services, inventory management, pharmacy automation, pharmacy management and packaging solutions.
Earnings Call
Q2/2025
Estimate EPS4.1
Actual EPS4.42
Estimate Revenue75.80B
Actual Revenue75.50B
Navigating Contradictions: Insights from the Latest Earnings Call on Health Systems, Tariffs, and Specialty Growth
May 19,2025 04:19
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS3.82
Actual EPS4
Estimate Revenue80.12B
Actual Revenue80.70B
International Business Insights: Contradictions in Performance and RCA Integration from Q3 2025 Earnings Call
Aug 06,2025 12:31
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
COR has released its 2025 Q4 earnings. EPS was reported at 3.84, versus the expected 3.79, beating expectations. The chart below visualizes how COR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
COR has released its 2025 Q4 earnings report, with revenue of 83.73B, reflecting a YoY change of 5.92%, and net profit of -333.07M, showing a YoY change of -4561.17%. The Sankey diagram below clearly presents COR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
